| Stage | NVDA | % of rev | PLAB | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $96.2B | 100.00% | $216M | 100.00% | NVDA ×445.37 |
| Gross profit | $72.1B | 74.98% | $72M | 33.20% | NVDA +41.8pp |
| Operating income | $63.7B | 66.24% | $46M | 21.06% | NVDA +45.2pp |
| Pre-tax income | $71.5B | 74.32% | $55M | 25.40% | NVDA +48.9pp |
| Net income | $59.7B | 62.03% | $44M | 20.31% | NVDA +41.7pp |
| Stage | NVDA | PLAB | Gap · A − B |
|---|---|---|---|
| Revenue | $96.2B100.00% | $216M100.00% | NVDA ×445.37 |
| Gross profit | 74.98%$72.1B | 33.20%$72M | NVDA +41.8pp |
| Operating income | 66.24%$63.7B | 21.06%$46M | NVDA +45.2pp |
| Pre-tax income | 74.32%$71.5B | 25.40%$55M | NVDA +48.9pp |
| Net income |
| 62.03%$59.7B |
| 20.31%$44M |
| NVDA +41.7pp |
No disclosed counterparties: PLAB.
None